Larson AM. Acetaminophen hepatotoxicity. Clin Liver Dis. 2007;11(3):525-48, vi.
Pharmacology: Acetaminophen is metabolized through cytochrome P450 system to form toxic NAPQI metabolite, which requires glutathione to detoxify. Clinical stages of acetaminophen overdose: Stage 1 (<24 hr): Abd pain, N/V, anorexia, lethargy, diaphoresis; normal labs Stage 2 (24-72 hr): RUQ abdominal pain, jaundice, rising AST/ ALT/INR values Stage 3 (72-96 hr): Peak hepatotoxicity, renal insufficiency, and death vs. mild symptoms if treated Stage 4 (4 days-2 wk): 70% survive acute liver failure; resolution of symptoms Toxic ingestion dose: 150 mg/kg Lab: Draw serum acetaminophen level at 4 hours post-ingestion. Treatment: 1. Activated charcoal - Of benefit <1 hour of ingestion and possible benefit beyond 1 hour 2. N-acetylcysteine (PO or IV) - Precursor to glutathione - Start within 8-10 hours if: Above possible hepatic toxicity line Estimated single ingestion of acetaminophen >150 mg/kg Time of ingestion unknown and serum level > 10 mcg/mL Lab evidence of hepatotoxicity and history of excessive ingestion Repeated ingestion and a serum level >10 mcg/mL - PO: 140 mg/kg first dose and then 70 mg/kg every 4 hours. Typically treat for 20 hours for uncomplicated overdose. - IV: 150 mg/kg first dose over 1 hour, then 50 mg/kg for first 4 hours, then 100 mg/kg over next 16 hours (total dose = 300 mg/kg over 20 hours) Rumack Matthew Nomogram Use for single time-point ingestion only. Does not predict toxicity in chronic ingestion.
Possible hepatic toxicity line is 25% lower than probable hepatic toxicity to account for lab assay variability.